glp-1 heart issues Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology Cardiologist: GLP1 Medications Reduce Heart

Increased Na+/H+-Exchange Activity Is the Cause of Increased [Na+]i and Underlies Disturbed Calcium Handling in the Rabbit Pressure and Volume Overload Heart Failure Model

The Impact of Metabolic Health on Joint Health Risk of Metabolic Syndrome in Psoriatic Arthritis Psoriatic Arthritis Super Responders: Early Detection and Metabolic Health Matter

Santiago JA, Karthikeyan M, Lackey M, Villavicencio D, Potashkin JA

Glucagon-like peptide-1 receptor agonists for weight loss in adult patients without diabetes

Onceweekly dulaglutide versus oncedaily liraglutide in metformintreated patients with type 2 diabetes (AWARD6): a randomised, openlabel, phase 3, noninferiority trial

Comparative effects of prolonged and intermittent stimulation of the glucagon-like Peptide 1 receptor on gastric emptying and glycemia